| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $3.40B | +3.4% |
| Cost of Revenue | $1.79B | +5.3% |
| R&D Expense | $65.0M | +3.7% |
| SG&A Expense | $218.5M | +6.2% |
| Operating Income | $226.3M | -8.5% |
| Pre-tax Income | $97.0M | -24.5% |
| Income Tax | $84.1M | +270.4% |
| Net Income | $15.0M | -91.4% |
| EPS (Basic) | $0.60 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $234.0M | +14.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $68.3M | +5.7% |
| Inventory | $112.9M | +16.3% |
| Current Assets | $502.6M | +9.7% |
| Total Assets | $1.97B | +4.0% |
| Current Liabilities | $758.7M | +14.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $298.1M | -15.0% |
| Capital Expenditures | $89.0M | +62.1% |
| Investing Cash Flow | -$140.8M | -157.7% |
| Financing Cash Flow | -$135.9M | +38.9% |
| Free Cash Flow | $209.0M | -29.3% |
| -91.0% |
| EPS (Diluted) | $0.58 | -91.0% |
| Long-term Debt |
| $1.58B |
| -1.0% |
| Total Liabilities | $2.53B | +4.7% |
| Stockholders' Equity | -$583.5M | -6.1% |